AstraZeneca to Pay $425 Million in Settlement for Nexium and Prilosec Lawsuits AstraZeneca has agreed to pay $425 million to resolve lawsuits filed by consumers who experienced kidney injuries while using its heartburn medications Nexium and Prilosec. The details of the settlement have not been disclosed, but it effectively resolves the product liability claims that …
A federal judge has declined to block the Medicare Drug Price Negotiation program, requiring companies to cooperate with the government for now. This ruling comes ahead of the Oct. 1 deadline, by which drugmakers must sign agreements to engage in the negotiation process or face penalties. U.S. District Judge Michael J. Newman rejected a request …
The Pfizer, Moderna, and AstraZeneca Covid-19 vaccines have been associated with unexpected vaginal bleeding in older women and women on birth control. While changes in bleeding and periods in menstruating women after vaccination have been known for years, few studies have investigated the impact on women who don’t normally menstruate, such as the elderly and …
AstraZeneca, the renowned Covid vaccine manufacturer, has filed a lawsuit against the US government in response to legislation aimed at reducing prescription drug prices. The legal challenge targets President Joe Biden’s Inflation Reduction Act (IRA), which grants the US government the authority to negotiate prices on behalf of Medicare beneficiaries. The implementation of these new …
The Centers for Disease Control and Prevention (CDC) announced on Thursday the official recommendation for the first preventive treatment for Respiratory syncytial virus (RSV) in infants. This recommendation came shortly after an endorsement from the Advisory Committee on Immunization Practices (ACIP). The CDC Director, Mandy Cohen, adopted the ACIP’s guidance regarding the administration of nirsevimab, …
The sales of the Oxford AstraZeneca Covid vaccine have plummeted to zero as health officials shift their support to safer alternatives. In the three months leading up to June, the Anglo-Swedish pharmaceutical group recorded no sales for the vaccine, referred to as Vaxzevria, compared to $455 million (£350 million) in revenue during the same period …
FDA Approves Vaccine to Combat Fatal Winter Virus in Infants By Emily Joshu, Health Reporter For Dailymail.Com Updated: 23:34 BST, 17 July 2023 The Food and Drug Administration (FDA) has recently approved an innovative vaccine developed by Sanofi and AstraZeneca to combat respiratory syncytial virus (RSV) in infants and toddlers. The vaccine is set to …